Brief: NanoString And Parker Institute For Cancer Immunotherapy Collaborate To Optimize Cell Therapies To Treat Cancer

NS Wind Down Co

15/06/2021 12:03

June 15 (Reuters) - NanoString Technologies Inc  NSTG.O :
    * NANOSTRING AND PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
COLLABORATE TO OPTIMIZE CELL THERAPIES TO TREAT CANCER
    * NANOSTRING TECHNOLOGIES INC - COLLABORATION WILL UTILIZE
NCOUNTER ANALYSIS SYSTEM TO CHARACTERIZE CAR-T REGIMENS DESIGNED
TO IMPROVE PATIENT OUTCOMES

Source text for Eikon:  ID:nBw4FhBqka 
Further company coverage:  NSTG.O 

 ((Reuters.Briefs@thomsonreuters.com;))